Financhill
Sell
37

IRIX Quote, Financials, Valuation and Earnings

Last price:
$1.51
Seasonality move :
6.95%
Day range:
$1.56 - $1.62
52-week range:
$1.27 - $3.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.53x
P/B ratio:
10.02x
Volume:
21.1K
Avg. volume:
35.5K
1-year change:
-40.15%
Market cap:
$26.3M
Revenue:
$51.9M
EPS (TTM):
-$0.67

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Upside
    No price target exists because of limited analyst coverage.
  • Price Target Downside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, IRIDEX has 26.58% upside to fair value with a price target of -- per share.

IRIX vs. S&P 500

  • Over the past 5 trading days, IRIDEX has underperformed the S&P 500 by -3.63% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • IRIDEX does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • IRIDEX revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter IRIDEX reported revenues of $11.6M.

Earnings Growth

  • IRIDEX earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter IRIDEX reported earnings per share of -$0.12.
Enterprise value:
25.2M
EV / Invested capital:
--
Price / LTM sales:
0.53x
EV / EBIT:
--
EV / Revenue:
0.52x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
-3.60x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$18.8M
Return On Assets:
-33.47%
Net Income Margin (TTM):
-22.79%
Return On Equity:
-157.91%
Return On Invested Capital:
-146.36%
Operating Margin:
-16.15%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $57M $54.6M $48.4M $12.9M $11.6M
Gross Profit $24.7M $23.6M $18.8M $5.6M $4.3M
Operating Income -$8.5M -$8.3M -$10.9M -$1.7M -$1.9M
EBITDA -$6.3M -$6.8M -$9.1M -$1.3M -$1.6M
Diluted EPS -$0.55 -$0.48 -$0.67 -$0.11 -$0.12
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $25.6M $43.9M $38.3M $27.3M $24.3M
Total Assets $28.5M $50.5M $45M $34.9M $30.2M
Current Liabilities $9.2M $13M $13.6M $10.3M $15.9M
Total Liabilities $11.2M $25.2M $26.9M $22.9M $27.5M
Total Equity $17.3M $25.3M $18.1M $12.1M $2.6M
Total Debt $2.5M -- -- -- $2.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$9.7M -$7.4M -$7M -$1.8M -$3.1M
Cash From Investing -$240K -$224K $28K -$82K -$1K
Cash From Financing -$34K -$50K $2.9M -$24K $2.8M
Free Cash Flow -$9.9M -$7.6M -$7M -$1.9M -$3.1M
IRIX
Sector
Market Cap
$26.3M
$43.5M
Price % of 52-Week High
43.29%
47.5%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-40.15%
-35.82%
Beta (5-Year)
0.836
0.753
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $1.63
200-day SMA
Sell
Level $1.95
Bollinger Bands (100)
Sell
Level 1.55 - 1.79
Chaikin Money Flow
Buy
Level 2.6M
20-day SMA
Sell
Level $1.64
Relative Strength Index (RSI14)
Sell
Level 40.37
ADX Line
Sell
Level 11.72
Williams %R
Buy
Level -85.7143
50-day SMA
Sell
Level $1.70
MACD (12, 26)
Sell
Level -0.02
25-day Aroon Oscillator
Sell
Level -96
On Balance Volume
Neutral
Level 18.3M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-1.0619)
Sell
CA Score (Annual)
Level (-1.8044)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (3.8546)
Sell
Piotroski F Score (Annual)
Level (3)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Stock Forecast FAQ

In the current month, IRIX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IRIX average analyst price target in the past 3 months is --.

  • Where Will IRIDEX Stock Be In 1 Year?

    According to analysts, the consensus estimate is that IRIDEX share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About IRIDEX?

    Analysts are divided on their view about IRIDEX share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that IRIDEX is a Sell and believe this share price will drop from its current level to --.

  • What Is IRIDEX's Price Target?

    The price target for IRIDEX over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is IRIX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for IRIDEX is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of IRIX?

    You can purchase shares of IRIDEX via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase IRIDEX shares.

  • What Is The IRIDEX Share Price Today?

    IRIDEX was last trading at $1.51 per share. This represents the most recent stock quote for IRIDEX. Yesterday, IRIDEX closed at $1.58 per share.

  • How To Buy IRIDEX Stock Online?

    In order to purchase IRIDEX stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Will Palantir Stock Be Worth in 2030?
What Will Palantir Stock Be Worth in 2030?

Palantir Technologies (NYSE: PLTR) has emerged from a growth slowdown…

Is Rollins Stock a Buy, Sell or Hold?
Is Rollins Stock a Buy, Sell or Hold?

Pest control giant Rollins (NYSE:ROL) is the parent company of…

Why Did Bill Ackman Buy Uber?
Why Did Bill Ackman Buy Uber?

In early 2025, billionaire investor Bill Ackman, CEO of Pershing…

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 111x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
65
ATEX alert for Feb 12

Anterix [ATEX] is down 0.72% over the past day.

Buy
87
GDS alert for Feb 12

GDS Holdings [GDS] is up 0.32% over the past day.

Sell
30
SPSC alert for Feb 12

SPS Commerce [SPSC] is up 0.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock